Home
Clinical Resources Search
PQI: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

Download PQI pdf 0.27MB

Last Updated: March 6, 2025

By: Andrew Ruplin, PharmD

About this PQI

The purpose of this PQI is to understand the management techniques and interventions related to the utilization of the combination treatment of enfortumab vedotin-ejfv and pembrolizumab.

More About This PQI

PQI:

Enfortumab-Vedotin-Padcev_PQI_NCODA pdf 0.25MB

PQI in Action Articles:

Enfortumab_vedotin_padcev_carcinoma pdf 3.37MB

PQI in Action Articles:

Enfortumab_vedotin_padcev_carcinoma2 pdf 1.27MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Urothelial Carcinoma Enfortumab Vedotin Keytruda Padcev Pembrolizumab

PQI

Frequently Searched

Supported by

Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

About this PQI

More About This PQI

PQI:

PQI in Action Articles:

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma

The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024

The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

Readiness Tracker

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Treatment Support Kit: Regorafenib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Sacituzumab govitecan (Trodelvy®): Management of Neutropenia and Diarrhea

PQI Podcast S6 Ep 7: Urology Clinic Best Practices

PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma

PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2

PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma

PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2

PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma

The PQI Podcast S4 Ep 20: Cancer Immunotherapy

PQI: Axitinib (Inlyta®) Plus Pembrolizumab (Keytruda®) for Advanced Renal Cell Carcinoma

PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma

PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2

PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma

The PQI Podcast S4 Ep 20: Cancer Immunotherapy

PQI: Axitinib (Inlyta®) Plus Pembrolizumab (Keytruda®) for Advanced Renal Cell Carcinoma

The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024

PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting